Castle Biosciences, Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

32.52

-1.68 (-4.91%)

At close: Nov 6, 2026, 4:00 PM EST

32.68

+0.16 (0.48%)

After-hours: Nov 6, 2026, 7:59 PM EST

Castle Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	77.99	116.73	119.71	98.84	122.95	329.63
Short-Term Investments	199.67	182.78	173.42	144.26	135.68	-
Cash & Short-Term Investments	277.67	299.51	293.13	243.1	258.63	329.63
Cash Growth	-3.44%	2.17%	20.58%	-6.00%	-21.54%	-19.57%
Accounts Receivable	52.1	43.38	51.22	38.3	23.48	17.28
Other Receivables	1.3	1.1	0.6	-	-	-
Receivables	53.4	44.48	51.82	38.3	23.48	17.28
Inventory	10.38	10.25	8.14	7.94	3.98	2.02
Prepaid Expenses	15.41	6.86	7.07	6.29	6.21	4.81
Total Current Assets	356.86	361.1	360.15	295.64	292.29	353.74
Property, Plant & Equipment	125.43	112.24	62.71	37.74	26.5	16.88
Goodwill	10.69	10.69	10.69	10.69	10.69	-
Other Intangible Assets	80.8	88.88	95.54	106.64	115.66	88.92
Other Long-Term Assets	5.63	5.65	2.15	2.63	2.2	3.02
Total Assets	579.41	578.56	531.24	453.34	447.33	462.57

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	13.23	18.71	6.9	10.27	4.73	2.55
Accrued Expenses	40.62	45.1	38.7	35.26	29.21	20.5
Current Portion of Long-Term Debt	4.17	0.42	0.28	-	-	-
Current Portion of Leases	1.64	1.43	1.77	1.21	1.93	1.28
Current Income Taxes Payable	-	-	-	0.4	-	-
Other Current Liabilities	7.96	3.02	1.75	0.54	0.27	0.56
Total Current Liabilities	67.61	68.68	49.39	47.67	36.13	24.89
Long-Term Debt	5.92	9.64	9.75	-	-	-
Long-Term Leases	24.85	25.53	14.66	14.2	11.62	7.02
Long-Term Deferred Tax Liabilities	2.4	2.34	1.61	0.21	0.43	0.64
Other Long-Term Liabilities	0.19	1.5	-	-	-	18.29
Total Liabilities	100.96	107.68	75.4	62.07	48.18	50.83

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	723.87	694.86	655.7	609.48	560.41	505.48
Retained Earnings	-244.97	-224.28	-200.13	-218.37	-160.91	-93.77
Comprehensive Income & Other	-0.49	0.27	0.23	0.14	-0.38	-
Total Common Equity	478.44	470.87	455.84	391.27	399.15	411.74
Shareholders' Equity	478.44	470.87	455.84	391.27	399.15	411.74
Total Liabilities & Equity	579.41	578.56	531.24	453.34	447.33	462.57

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	36.57	37.02	26.45	15.41	13.55	8.31
Net Cash (Debt)	241.09	262.49	266.69	227.69	245.08	321.33
Net Cash Growth	-3.72%	-1.57%	17.13%	-7.09%	-23.73%	-21.60%
Net Cash Per Share	8.06	9.06	9.12	8.50	9.41	12.78
Filing Date Shares Outstanding	30.82	29.73	28.51	27.45	26.58	25.41
Total Common Shares Outstanding	30.77	29.69	28.48	27.41	26.55	25.38
Working Capital	289.25	292.42	310.76	247.97	256.16	328.86
Book Value Per Share	15.55	15.86	16.00	14.27	15.03	16.22
Tangible Book Value	386.95	371.3	349.61	273.93	272.8	322.82
Tangible Book Value Per Share	12.58	12.51	12.27	9.99	10.27	12.72
Land	7.25	7.25	7.25	-	-	-
Machinery	57.04	42.6	32.48	22.92	15.35	7.47
Construction In Progress	0.3	51.06	9.61	0.64	1.28	0.03
Leasehold Improvements	25.98	14.83	14.62	9.99	5.17	5.04

SEC Filings: 10-K · 10-Q